Article
Oncologists Raise a Voice Against Cancer Drug Costs
Hagop Kantarjian, MD, from MD Anderson is at it again. A special publication online, written in collaboration with S. Vincent Kumar, MD, from the Mayo Clinic, highlights the dismal state of the economics behind high oncology drug costs and recommends solutions.
Increasingly high prices for cancer drugs are affecting patient care in the United States. and the American healthcare system overall, say the authors of a special article published online in the journal Mayo Clinic Proceedings.
“Americans with cancer pay 50 percent to 100 percent more for the same patented drug than patients in other countries,” says S
, of Mayo Clinic Cancer Center
,
who is one of the authors. “As oncologists we have a moral obligation to advocate for affordable cancer drugs for our patients.”
. Vincent Raj Kumar
Link to the news release by the Mayo Clinic: http://mayocl.in/1Gd7cMB
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
